Medpace Holdings (MEDP) Depreciation & Amortization - Total (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Depreciation & Amortization - Total came in at $6.6 million in Q2 2026, down 3.28% on a YoY basis from $6.8 million in Q2 2025, and down 2.9% quarter-over-quarter from $6.8 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Depreciation & Amortization - Total (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Depreciation & Amortization - Total for 12 consecutive years, with $6.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization - Total fell 3.28% year-over-year to $6.6 million; the trailing twelve-month figure through Jun 2026 stood at $27.0 million (down 2.66% YoY), and the FY2025 full-year result was $27.2 million, down 2.19% from the prior year.
- Depreciation & Amortization - Total eased to $6.6 million in Q2 2026 per MEDP's latest filing, from $6.8 million in the prior quarter.
- Across five years, Depreciation & Amortization - Total topped out at $7.2 million in Q3 2024 and bottomed at $4.3 million in Q1 2022.
- Historically, Depreciation & Amortization - Total has averaged $6.2 million across 5 years, with a median of $6.6 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization - Total climbed 27.83% in 2023, then declined 4.82% in 2025.
- Over 5 years, Depreciation & Amortization - Total stood at $5.1 million in 2022, then advanced by 26.62% to $6.4 million in 2023, then advanced by 11.26% to $7.1 million in 2024, then fell by 3.21% to $6.9 million in 2025, then slipped by 5.22% to $6.6 million in 2026.
- According to Business Quant data, Depreciation & Amortization - Total over the past three periods registered $6.6 million, $6.8 million, and $6.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 6.56 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | - |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.56 Mn |
| Mar 31, 2026 | 6.75 Mn |
| Dec 31, 2025 | 6.92 Mn |
| Sep 30, 2025 | 6.81 Mn |
| Jun 30, 2025 | 6.78 Mn |
| Mar 31, 2025 | 6.69 Mn |
| Dec 31, 2024 | 7.15 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 6.87 Mn |
| Mar 31, 2024 | 6.63 Mn |
| Dec 31, 2023 | 6.42 Mn |
| Sep 30, 2023 | 6.33 Mn |
| Jun 30, 2023 | 5.97 Mn |
| Mar 31, 2023 | 5.41 Mn |
| Dec 31, 2022 | 5.07 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.71 Mn |
| Mar 31, 2022 | 4.27 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | 4.06 Mn |